medigraphic.com
Revista Médica Sinergia

2021, Número 05

Siguiente >>

Revista Médica Sinergia 2021; 6 (05)


Síndrome inflamatorio multisistémico pediátrico

Fung FMP, Vargas GA, León QSP

Idioma: Español
Referencias bibliográficas: 25
Paginas: 1-11
Archivo PDF: 226.70 Kb.


RESUMEN

El síndrome inflamatorio multisistémico pediátrico es un síndrome clínico descrito en los últimos meses en niños y adolescentes, asociado a una infección activa o reciente por SARS-CoV-2, el virus que causa COVID-19. Se caracteriza por fiebre persistente, valores elevados de marcadores de inflamación y disfunción de uno o múltiples órganos. Puede incluir características sugestivas del síndrome de Kawasaki o síndrome de shock tóxico. El diagnóstico se basa en factores clínicos, de laboratorio, ecocardiográficos y epidemiológicos. Los pacientes con enfermedad leve pueden tratarse de forma conservadora, mientras que los pacientes con una enfermedad más grave deben recibir inmunoglobulina intravenosa. La mayoría de los pacientes responden rápidamente al tratamiento.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. World Health Organization. Multisystem inflammatory syndrome in children and adolescents temporally related to COVID-19: Scientific Brief 15 May 2020. Who. 2020;10(May):1–9.

  2. Center for Disease Control and Prevention. Information for Healthcare Providers about Multisystem Inflammatory Syndrome in Children (MIS-C). 2021.

  3. Royal College of Paediatrics and Child Health. Guidance: Paediatric multisystem inflammatory syndrome temporally associated with COVID-19. 2020.

  4. García-Salido A, Antón J, Martínez-Pajares JD, Giralt Garcia G, Gómez Cortés B, Tagarro A, et al. Spanish consensus document on diagnosis, stabilisation and treatment of pediatric multisystem inflammatory syndrome related to SARS-CoV-2 (SIM-PedS). An Pediatr. 2021;94(2):116.e1-116.e11. https://doi.org/10.1016/j.anpedi.2020.09.005

  5. Whittaker E, Bamford A, Kenny J, Kaforou M, Jones CE, Shah P, et al. Clinical Characteristics of 58 Children with a Pediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2. JAMA - J Am Med Assoc. 2020;324(3):259–69. https://doi.org/10.1001/jama.2020.10369

  6. Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020;395(10237):1607–8. http://dx.doi.org/10.1016/S0140-6736(20)31094-1

  7. Feldstein LR, Rose EB, Horwitz SM, Collins JP, Newhams MM, Son MBF, et al. Multisystem Inflammatory Syndrome in U.S. Children and Adolescents. N Engl J Med. 2020;383(4):334–46. https://doi.org/10.1056/nejmoa2021680

  8. Abrams JY, Godfred-Cato SE, Oster ME, Chow EJ, Koumans EH, Bryant B, et al. Multisystem Inflammatory Syndrome in Children Associated with Severe Acute Respiratory Syndrome Coronavirus 2: A Systematic Review. J Pediatr. 2020;226:45-54.e1. https://doi.org/10.1016/j.jpeds.2020.08.003

  9. Ahmed M, Advani S, Moreira A, Zoretic S, Martinez J, Chorath K, et al. Multisystem inflammatory syndrome in children: A systematic review. EClinicalMedicine. 2020;26:100527. https://doi.org/10.1016/j.eclinm.2020.100527

  10. Brodsky NN, Ramaswamy A, Lucas CL. The Mystery of MIS-C Post-SARS-CoV-2 Infection. Trends Microbiol. 2020;28(12):956–8. https://doi.org/10.1016/j.tim.2020.10.004

  11. Carter MJ, Shankar-Hari M, Tibby SM. Paediatric Inflammatory Multisystem Syndrome Temporally- Associated with SARS-CoV-2 Infection: An Overview. Intensive Care Med. 2021;47(1):90–3. https://doi.org/10.1007/s00134-020-06273-2

  12. American College of Rheumatology MIS-C and COVID-19 Related Hyperinflammation Task Force. Clinical Guidance for Pediatric Patients with Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2 and Hyperinflammation in COVID-19. Am Coll Rheumatol. 2020;0(0):1–5.

  13. Chiotos K, Bassiri H, Behrens EM, Blatz AM, Chang J, Diorio C, et al. Multisystem Inflammatory Syndrome in Children During the Coronavirus 2019 Pandemic: A Case Series. J Pediatric Infect Dis Soc. 2020;9(3):393–8. https://doi.org/10.1093/jpids/piaa069

  14. Sethuraman U, Kannikeswaran N, Ang J, Singer A, Miller J, Haddad R, et al. Multisystem inflammatory syndrome in children associated with novel coronavirus SARS-CoV-2: Presentations to a pediatric emergency department in Michigan. Am J Emerg Med. 2021;39:164–7. https://doi.org/10.1016/j.ajem.2020.10.035

  15. Zou H, Lu J, Liu J, Wong JH yuen, Cheng S, Li Q, et al. Characteristics of pediatric multi-system inflammatory syndrome (PMIS) associated with COVID-19: a meta-analysis and insights into pathogenesis. Int J Infect Dis. 2021;102:319–26. https://doi.org/10.1016/j.ijid.2020.11.145

  16. Jiang L, Tang K, Levin M, Irfan O, Morris SK, Wilson K, et al. COVID-19 and multisystem inflammatory syndrome in children and adolescents. Lancet Infect Dis. 2020;20(11):e276–88. http://dx.doi.org/10.1016/S1473-3099(20)30651-4

  17. Loke YH, Berul CI, Harahsheh AS. Multisystem inflammatory syndrome in children: Is there a linkage to Kawasaki disease? Trends Cardiovasc Med. 2020;30(7):389–96. https://doi.org/10.1016/j.tcm.2020.07.004

  18. Rowley AH. Multisystem Inflammatory Syndrome in Children and Kawasaki Disease: Two Different Illnesses with Overlapping Clinical Features. J Pediatr. 2020;224(April 2020):129–32. https://doi.org/10.1016/j.jpeds.2020.06.057

  19. Yeo WS, Ng QX. Distinguishing between typical Kawasaki disease and multisystem inflammatory syndrome in children (MIS-C) associated with SARS-CoV-2. Med Hypotheses. 2020;144(August 2020):110263. https://doi.org/10.1016/j.mehy.2020.110263

  20. Carlin RF, Fischer AM, Pitkowsky Z, Abel D, Sewell TB, Landau EG, et al. Discriminating Multisystem Inflammatory Syndrome in Children Requiring Treatment from Common Febrile Conditions in Outpatient Settings. J Pediatr. 2021;229:26-32.e2. https://doi.org/10.1016/j.jpeds.2020.10.013

  21. Noval Rivas M, Porritt RA, Cheng MH, Bahar I, Arditi M. COVID-19–associated multisystem inflammatory syndrome in children (MIS-C): A novel disease that mimics toxic shock syndrome—the superantigen hypothesis. J Allergy Clin Immunol. 2021;147(1):57–9. https://doi.org/10.1016/j.jaci.2020.10.008

  22. Antúnez-Montes OY, Escamilla MI, Figueroa-Uribe AF, Arteaga-Menchaca E, Lavariega-Saráchaga M, Salcedo-Lozada P, et al. COVID-19 and Multisystem Inflammatory Syndrome in Latin American Children: A Multinational Study. Pediatr Infect Dis J. 2020;40(1):1–6. https://doi.org/10.1097/INF.0000000000002949

  23. White M, Tiesman B, Handforth J, Kenny J. Paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS): The Evelina Experience. Arch Dis Child. 2020;105(11):1025–7. https://doi.org/10.1136/archdischild-2020-319554

  24. Nijman RG, De Guchtenaere A, Koletzko B, Ross Russell R, Copley S, Titomanlio L, et al. Pediatric Inflammatory Multisystem Syndrome: Statement by the Pediatric Section of the European Society for Emergency Medicine and European Academy of Pediatrics. Front Pediatr. 2020;8(August):1–10. https://doi.org/10.3389/fped.2020.00490

  25. Dove ML, Jaggi P, Kelleman M, Abuali M, Ang JY, Ballan W, et al. Multisystem Inflammatory Syndrome in Children: Survey of Protocols for Early Hospital Evaluation and Management. J Pediatr. 2021;229:33–40. https://doi.org/10.1016/j.jpeds.2020.10.026




2020     |     www.medigraphic.com